Mesterolone treatment of patients with pathospermia.
The response to Mesterolone, in doses of 25 mg/day, was examined in 42 pathospermic patients. Treatment lasted for 100 days. The pronounced response to the Mesterolone treatment was observed in hypozoo- and oligozoospermia with low initial fructose content in the ejaculate. Fructose content attained its normal range after the treatment. During the therapeutic period 11 wives became pregnant. The authors conclude that Mesterolone does not influence plasma FSH, LH and testosterone levels, it has only peripheral effects.
D000328:Adult; D013196:Dihydrotestosterone / Q000031:analogs & derivatives*; D005640:Follicle Stimulating Hormone / Q000097:blood; D005632:Fructose / Q000032:analysis; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008655:Mesterolone / Q000008:administration & dosage / Q000627:therapeutic use*; D009845:Oligospermia / Q000188:drug therapy*; D013094:Spermatozoa / Q000032:analysis; D013739:Testosterone / Q000097:blood
D013196:Dihydrotestosterone; D008655:Mesterolone; D005632:Fructose; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone